July 9, 2025 · Form 4 insider transaction
Shulman Joseph sold 3,985 shares of Rhythm Pharmaceuticals, Inc. at $80.00 per share, a transaction worth $318.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 8, 2024.